Reply to thread

They changed the IC plan for Q2 at the start of Q3…


They have been promising cars for 7 years.


No titration for bipolar still.


Gastro failed the phase 3 study.


Revenue on Fanapt and Ponvory is going terribly.


Seems like Vanda as usual.